Reports Q4 revenue $307M, consensus $300.01M. “We delivered solid financial results for Q4 2024, including returning to year-over-year revenue ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Omnicell (OMCL – Research Report). The company’s shares ...

Healthcare tech company Omnicell (NASDAQ:OMCL) will be reporting results tomorrow morning. Here’s what to expect. Omnicell beat analysts’ revenue expectations by 0.6% last quarter, reporting ...

In the latest quarter, 4 analysts provided ratings for Omnicell (NASDAQ:OMCL), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below ...

Omnicell OMCL is advancing toward the industry-defined vision of Autonomous Pharmacy by leveraging automation and advanced services across its cloud-based platform. The strength of the company’s ...

FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter ...

These bank stocks are all $50 billion or more in market value with a 3% yield or higher.

If you’re on the fence about investing in Merit Medical Systems, Inc., Omnicell or Inc. because you’re not sure how they measure up, it’s important to compare them on a few factors before making your ...